Drug Patent Database Subscription: A Review of Drug Patent Expiry Dates

DUBLIN, Dec. 31, 2019 /PRNewswire/ -- The "Drug Patent Database Subscription: Drugs in Development" newsletter has been added to ResearchAndMarkets.com's offering.

This subscription was created to answer a simple question: When do drug patents expire? Your needs evolve as the industry keeps changing. Since then dozens of additional datasets have been added by aggressive adaptation based on your needs.

This subscription for the Drugs in Development portion of the database offers information on:

• Drug Candidates in Phase I-III Clinical Trials
• US & International Patents, including Active and Expired Patents in 134 Countries
• Clinical Trials
• API Vendors

Global biopharmaceutical markets face constant change. To remain competitive you need to anticipate what's next. If you are expanding into new markets, looking inward for growth opportunities, or seeking to improve your current activities and need to find information quickly, this subscription can help.

With a single click, you can find answers to complex questions such as:

• Which drugs have no patents and no competitors?
• What are all the patents covering any given dosage form (e.g. injectables)?
• What is the earliest generic entry opportunity date for a drug with dozens of patents?

The subscription focuses on delivering the greatest value and lowest cost by directing attention to high-impact problems, giving you the relevant information you need.

Some of the companies featured include:

• 3M Pharmaceuticals
• Abbott Laboratories
• AbbVie
• Acadia Pharmaceuticals
• Advanced Chemical Industries
• Advaxis
• ACG Worldwide
• Ajanta Pharma
• Alcon
• Alembic Pharmaceuticals Ltd
• Aspen Pharmacare
• Astellas Pharma
• AstraZeneca
• Axcan Pharma
• Bargn Farmaceutici Phils Co
• Barr Pharmaceuticals
• Bausch & Lomb
• Baxalta
• Baxter International
• Bayer Schering Pharma AG
• Beximco Pharmaceuticals Ltd
• Bial
• Biocon
• Biogen
• Biolex
• Boehringer-Ingelheim
• Chugai Pharmaceutical Co.
• Clovis Oncology
• Concordia Healthcare
• Daiichi Sankyo
• Dainippon Sumitomo Pharma
• Dr. Reddy's Laboratories
• Eisai
• Elder Pharmaceuticals
• Eli Lilly and Company
• Emcure Pharmaceuticals
• Emergent BioSolutions
• GlaxoSmithKline
• Glenmark Pharmaceuticals
• GPC Biotech
• Grifols
• Grindeks
• G.F. Harvey Company
• Huadong Medicine
• Hoffmann-La Roche
• Horizon Pharma
• Hovione
• Incepta Pharmaceuticals
• Johnson & Johnson
• Julphar
• Juno Therapeutics
• Kimia Farma
• Kyowa Hakko Kirin
• Lundbeck
• Lupin Limited
• Mallinckrodt Pharmaceuticals
• MannKind Corporation
• Orion Pharma
• Otsuka Pharmaceutical Co.
• Panacea Biotec
• Par Pharmaceutical
• Patheon
• Perrigo
• Pfizer
• Salix Pharmaceuticals
• Sanofi
• SIGA Technologies
• Sigma Pharmaceuticals
• Taro Pharmaceuticals
• Turing Pharmaceuticals
• UCB

For more information about this newsletter visit https://www.researchandmarkets.com/r/ckk06h

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/drug-patent-database-subscription-a-review-of-drug-patent-expiry-dates-300980086.html

SOURCE Research and Markets